Shenzhen Chipscreen Biosciences Co. Ltd. Class ASSE: 688321

"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

Aug 13, 2026 · Issued by Shenzhen Chipscreen Biosciences Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shenzhen Chipscreen Biosciences Co. Ltd. Class A

"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure Regarding Acceptance of Clinical Trial Application for NW001Aug 6
"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Adjustment of Related Matters for the 2026 Restricted Share Incentive PlanAug 5
"Shenzhen Chipscreen Biosciences Co., Ltd."Self-inspection Report on Trading in the Company's Shares by Insiders with Access to Inside Information in Relation to the 2026 Restricted Share Incentive PlanAug 1
"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Acceptance of Clinical Trial Application for CS43158 TabletsJul 31

All Shenzhen Chipscreen Biosciences Co. Ltd. Class A news releases